35798 Federal Register / Vol. 86, No. 127 / Wednesday, July 7, 2021 / Notices 

technologies. Adding these measures to 

the NQDW survey instruments will 

impose minimal additional burden on 

states but will substantially improve the 

utility of the NQDW data to identify use 

of state quitlines by key tobacco use 

populations and through modalities 

other than telephone calls. Participation 

in the caller intake and follow-up 

interviews is voluntary for quitline 

callers. The estimated burden is 10 

minutes for a complete intake call 

conducted with an individual who calls 

on their own behalf. The estimated 

burden is one minute for a caller who 

requests information for someone else, 

as these callers complete only a subset 

of questions on the intake questionnaire. 

As a condition of funding (CDC–RFA– 

DP20–2001), the 54 cooperative 

agreement awardees are required to 

submit NQDW intake data quarterly, 

and services survey data semiannually. 

CDC recognizes that awardees incur 

additional burden for preparing and 

transmitting summary files with their 

de-identified caller intake and follow-up 

data. This burden is acknowledged in 

the instructions for transmitting the 

electronic data files. There is a net 

decrease in burden hours from the 

previous NQDW package estimate. This 

is primarily due to decreases in the 

overall number of telephone calls to the 

quitlines, which is estimated to be only 

partially offset by the use of other 

quitline modalities. The total estimated 

annual Burden Hours for the NQDW are 

68,088. There is no cost to respondents 

other than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

respondent 

(in hours) 

Total burden 

(in hours) 

Quitline participants who contact the quitline for 

help for themselves.

NQDW Intake Questionnaire (English-complete).405,053 1 10/60 67,509 

ASQ Intake Questionnaire (Chinese, Korean, 

or Vietnamese-complete).

1,686 1 10/60 281 

ASQ Seven-Month Follow-up Questionnaire .... 236 1 7/60 28 

Participants who contact the quitline on behalf 

of someone else.

NQDW Intake Questionnaire (English-subset)

ASQ Intake Questionnaire (Chinese, Korean, 

or Vietnamese-subset).

819 

249 

1 

1 

1/60 

1/60 

14 

4 

Tobacco Control Manager or their Designee/ 

quitline Service Provider.

Submission of NQDW Intake Questionnaire 

Electronic Data File to CDC.

54 4 1 216 

Submission of NQDW (ASQ) Seven-Month 

Follow-up Electronic Data File to CDC.

1 1 1 1 

NQDW Quitline Services Survey ...................... 54 2 20/60 36 

Total ............................................................ ........................................................................... ........................ ........................ ........................ 68,088 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–14441 Filed 7–6–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–21FS; Docket No. CDC–2021– 

0059] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled The Muscular Dystrophy 

Surveillance, Tracking, and Research 

Network (MD STARnet) Muscular 

Dystrophy Questionnaire: 

Understanding the impact of COVID–19, 

flu, pain, fatigue, pregnancy and 

infertility, on adults with muscular 

dystrophy. The purpose of the proposed 

study is to describe the epidemiology of 

COVID–19 and flu and the experience 

with pain, fatigue, pregnancy, and 

infertility for adults living with 

muscular dystrophy who are identified 

through the Muscular Dystrophy 

Surveillance Tracking and Research 

Network (MD STARnet). Information 

will be used to develop interventions 

that improve the lives of people with 

muscular dystrophy and their families. 

DATES: CDC must receive written 

comments on or before September 7, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0059 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7118; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 127 / Wednesday, July 7, 2021 / Notices 35799 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

The Muscular Dystrophy 

Surveillance, Tracking, and Research 

Network (MD STARnet) Muscular 

Dystrophy Questionnaire: 

Understanding the impact of COVID–19, 

flu, pain, fatigue, pregnancy and 

infertility, on adults with muscular 

dystrophy—New—National Center on 

Birth Defects and Developmental 

Disabilities (NCBDDD), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Since its establishment in 2002, the 

MD STARnet has been a populationbased surveillance system that aims to 

identify and collect clinical data on 

individuals with muscular dystrophy 

(MD) in select surveillance areas. MD 

STARnet identifies and collects data on 

cases at sources including healthcare 

facilities where patients with MD 

receive care, and administrative datasets 

such as vital records and hospital 

discharge data. While MDs are rare 

genetic diseases with an estimated 

prevalence of 16.1/100,000, they have a 

high impact on affected individuals, 

their families, and society. MDs can be 

classified into nine major groups: 

Duchenne muscular dystrophy (DMD), 

Becker muscular dystrophy (BMD), 

myotonic dystrophy (DM), 

facioscapulohumeral muscular 

dystrophy (FSHD), limb-girdle muscular 

dystrophy (LGMD), Congenital muscular 

dystrophy (CMD), Emery-Dreifuss 

muscular dystrophy (EDMD), and distal 

muscular dystrophy. A recent MD 

STARnet study has estimated the 

combined prevalence for DMD and BMD 

to be 1.92–2.48/10,000 males age 5–9 

years old. MD STARnet aims to improve 

understanding of MDs and ultimately 

the quality of life of people and their 

families living with MD. Individuals 

with MDs frequently report pain and 

fatigue, but studies have largely been 

conducted in clinic-based populations 

and included the three most common 

MDs. Population-based studies are 

needed to describe the frequency and 

management of pain and fatigue and 

their impact on the lives of individuals 

with various types of MD. 

The purpose of the proposed study is 

to describe the epidemiology of COVID– 

19 and flu and the experience with pain, 

fatigue, pregnancy, and infertility for 

adults living with muscular dystrophy 

who are identified through the Muscular 

Dystrophy Surveillance Tracking and 

Research Network (MD STARnet). 

Results generated from the study will 

provide a better understanding of (1) the 

occurrence, testing, treatment and 

severity of COVID–19 in relation to MD; 

(2) vaccination status and reasons for 

not receiving COVID–19 and flu 

vaccinations; (3) the frequency, 

intensity, and management of pain and 

fatigue; and (4) the effect of having 

muscular dystrophy on pregnancy and 

fertility on adults living with muscular 

dystrophy. Ultimately, this information 

can be used by stakeholders to develop 

interventions that improve the lives of 

people with muscular dystrophy and 

their families. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Adult males 18 and over ................... MD STARnet male questionnaire .... 1,794 1 15/60 449 

Adult females 18 and over ................ MD STARnet female questionnaire 1,574 1 20/60 525 

Total ........................................... ........................................................... ........................ ........................ ........................ 974 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–14437 Filed 7–6–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–21BG] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Prevention 

Research Centers National Program 

Evaluation Reporting System (PERS) to 

the Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on December 18, 2020 to obtain 

comments from the public and affected 

agencies. CDC received one comment 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 


khammond on DSKJM1Z7X2PROD with NOTICES